BRANFORD, Conn., February 13, 2025--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencing™ (NGPS™) at the US Human Proteome Organization’s 2025 conference in Philadelphia, Pennsylvania through a panel discussion and multiple poster presentations.
Sponsored Panel Discussion: Breaking Boundaries in Proteomics
Quantum-Si is sponsoring and moderating the panel event "Breaking Boundaries: How Next-Generation Protein Sequencing™ is Shaping the Future of Proteomics" on February 25 from 12:30-1:30 PM ET. The session will provide an overview of the latest research leveraging Quantum-Si’s Platinum® Pro benchtop instrument, including a pioneering protein barcoding kit for sample multiplexing and a new library preparation solution for lower sample input.
Following the presentation, Dr. Benjamin Garcia (Washington University in St. Louis), Dr. Stephanie Cologna (University of Illinois Chicago), and Dr. John Prensner (University of Michigan) will engage in a discussion on the transformative impact of NGPS on proteomics, its role in overcoming existing challenges, and its integration with complementary technologies.
Scientific Posters Highlighting NGPS Innovation
Protein Sequencing with Single Amino Acid Resolution Discerns Myopathy-linked Regions in Tropomyosin Peptidoforms
Reducing Protein Input for Next-Generation Protein Sequencing on the Platinum Instrument
Accurate Measurement of Peptide Variant Mixtures with Next-Generation Protein Sequencing
Protein Barcoding and Next-Generation Protein Sequencing for Multiplexed Protein Selection, Analysis and Tracking
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® line of instruments enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213208611/en/
Contacts
Investor Contact
Jeff Keyes
Chief Financial Officer
ir@quantum-si.com
Media Contact
Katherine Atkinson
SVP, Commercial Marketing
media@quantum-si.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.